"史帝富"普麗外用液

Nazione: Taiwan

Lingua: cinese

Fonte: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Principio attivo:

POLYTAR

Commercializzato da:

荷商葛蘭素史克藥廠股份有限公司台灣分公司 台北市中正區忠孝西路一段66號23-24樓 (86927438)

Codice ATC:

D05AA

Forma farmaceutica:

外用液劑

Composizione:

POLYTAR (8408001300) 0.25GM

Confezione:

瓶裝

Classe:

製　劑

Tipo di ricetta:

醫師藥師藥劑生指示藥品

Prodotto da:

STIEFEL LABORATORIES (PTE) LTD 103 GUL CIRCLE,SINGAPORE 629589 SG

Area terapeutica:

Tars

Indicazioni terapeutiche:

牛皮癬、濕疹、搔癢皮膚病。

Dettagli prodotto:

註銷日期: 2016/05/30; 註銷理由: 許可證已逾有效期; 有效日期: 2014/10/26; 英文品名: POLYTAR EMOLLIENT

Stato dell'autorizzazione:

已註銷

Data dell'autorizzazione:

1994-10-26

Foglio illustrativo

POLYTAR EMOLLIENT
TM
FORMULATIONS AND STRENGTH
POLYTAR EMOLLIENT
TM
each g contains: Polytar 0.25g
EXCIPIENTS
Light liquid paraffin
Octyl phenoxypolyethoxyethanol
Sorbitan mono-oleate
Isopropyl palmitate
Polyethylene glycol 400 dilaurate
CLINICAL INFORMATION
INDICATIONS
Psoriasis
Eczema
Pruritic dermatoses
DOSAGE AND ADMINISTRATION
Shake before use. 3 to 5 capfuls of POLYTAR EMOLLIENT
TM
should be added to a bath containing 8 inches of water and the patient
instructed to soak for15- 20 minutes or applied directly to the
affected area and pat dry.
The treatment could combine with UV radiation or other therapy.
CONTRAINDICATIONS
KNOWN HYPERSENSITIVITY TO COAL TAR, ARACHIS OIL (PEANUT OIL) OR TO ANY
OF THE EXCIPIENTS IN THE PREPARATION (SEE WARNINGS AND PRECAUTIONS)
THE FOLLOWING CONDITIONS SHOULD NOT BE TREATED WITH POLYTAR EMOLLIENT
TM
:
INFECTED OPEN SKIN LESIONS
SORE OR ACUTE PUSTULAR PSORIASIS
WARNINGS AND PRECAUTIONS
FOR CUTANEOUS USE ONLY.
COAL TAR PREPARATIONS MAY CAUSE IRRITANCY, THEREFORE CONTACT WITH
SENSITIVE AREAS, SUCH AS BROKEN OR VERY INFLAMED SKIN, SHOULD BE
AVOIDED.
IF IRRITATION DEVELOPS, TREATMENT SHOULD BE DISCONTINUED.
AVOID CONTACT WITH THE EYES. IF CONTACT OCCURS RINSE EYES THOROUGHLY
WITH WATER.
POLYTAR EMOLLIENT TM CAN STAIN SKIN AND CLOTHES. CONTACT WITH CLOTHES
SHOULD BE AVOIDED. SKIN STAINS WILL WEAR OFF AFTER TREATMENT IS
STOPPED.
IN RARE INSTANCES, TEMPORARY HAIR COLOUR CHANGES MAY OCCUR.
AS POLYTAR EMOLLIENT
TM MAY CAUSE INCREASED SENSITIVITY TO SUNLIGHT, EXPOSURE TO ARTIFICIAL
SOURCES OF UV LIGHT, SUCH AS SUNLAMPS SHOULD BE AVOIDED UNLESS THE UV
IS BEING USED AS PART OF A TREATMENT REGIMEN.
WHEN EXPOSURE TO STRONG SUNLIGHT CANNOT BE AVOIDED, PATIENTS SHOULD BE
ADVISED TO USE A SUNSCREEN PRODUCT AND WEAR PROTECTIVE CLOTHING. DUE
TO THE POTENTIAL FOR PHOTOSENSITIVITY, RESULTING IN GREATER RISK FOR
SUNBURN,
POLYTAR EMOLLIENT
TM SHOULD BE USED WITH CAUTION IN PATIENTS WITH A PERSONAL OR FAMILY
HISTORY OF SKIN CANCER.
IF A PATIENT HAS SUNBURN, THIS SHOULD BE RESOLVED BEFORE USING POLYTAR